Table. Monovalent hepatitis B vaccines for adolescents and adults
Vaccine | Age of vaccine recipient (years) | Dose (hepatitis B surface antigen protein) | Number of doses | Recommended schedule minimum intervals | Alternative schedule minimum intervals |
---|---|---|---|---|---|
Engerix-B (adult formulation) | 11–15 only | 20 μg | 2 |
|
Not applicable |
Engerix-B (paediatric formulation) | <20 | 10 μg | 3 |
|
OR
|
Engerix-B (adult formulation) | ≥20 | 20 μg | 3 |
|
OR
|
H-B-Vax II (adult formulation) | 11–15 only | 10 μg | 2 |
|
Not applicable |
H-B-Vax II (paediatric formulation) | <20 | 5 μg | 3 |
|
OR
|
H-B-Vax II (adult formulation) | ≥20 | 10 μg | 3 |
|
OR
|
H-B-Vax II (dialysis formulation) | ≥20 | 40 μg | 3 |
|
Not applicable |
Related diseases
Page history
Last updated
Last reviewed